• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of Fast Track designation requests granted

Dictionary: Fast track is an expedited drug development and review program for new drugs or biologics intended to treat serious or life-threatening conditions that demonstrate the potential to address unmet medical need.

Information is current as of March 31, 2014.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A5
Aug 2012N/A8
Sep 2012N/A2

FY 2012 3 month Total: 15

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

Number of applications approved under Accelerated Approval

Dictionary: Accelerated Approval is a regulatory pathway that allows for approval of drugs intended to treat serious or life-threatening diseases and that provide meaningful therapeutic benefit to patients over existing therapies, based on the use of surrogate endpoints reasonably likely to predict clinical benefits or a clinical endpoint other than survival or irreversible morbidity. (See also 21 CFR 314 Subpart H and 601 Subpart E)

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A1
Aug 2012N/A2
Sep 2012N/A0

FY 2012 3 month Total: 3

Number of First Generics approved

Dictionary: The first time that a particular drug is approved in generic form.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A13
Aug 2012N/A27
Sep 2012N/A5

FY 2012 3 month Total: 45

Number of orphan drugs addressing rare diseases approved

Dictionary: Orphan drugs are products intended for the safe and effective treatment of rare diseases/disorders that affect fewer than 200,000 U.S. patients.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A1
Aug 2012N/A2
Sep 2012N/A1

FY 2012 3 month Total: 4

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.